Stock Track | Personalis Soars 5.24% After-Hours on Bullish Analyst Ratings and Price Target Hike

Stock Track11-12

Shares of Personalis (PSNL) surged 5.24% in after-hours trading on Tuesday, following a series of bullish analyst reports and a notable price target increase. The genomic sequencing company's stock received a boost as multiple firms reaffirmed their positive outlook on the company's prospects.

H.C. Wainwright & Co. led the charge by raising its price target on Personalis to $13 from $10, while maintaining a Buy rating. This significant increase in the price target suggests growing confidence in the company's future performance. Additionally, both Guggenheim and BTIG reiterated their Buy ratings on the stock, further solidifying the positive sentiment among analysts.

While Morgan Stanley maintained its Equal-Weight rating on Personalis, the overall bullish stance from other prominent research firms appears to have overshadowed this neutral position. The collective positive analyst sentiment, particularly the raised price target, likely contributed to investors' enthusiasm, driving the stock's after-hours rally.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1146538948?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-12 05:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1146538948","market":"sg","top_or_hot":-1,"title":"Stock Track | Personalis Soars 5.24% After-Hours on Bullish Analyst Ratings and Price Target Hike","media":"Stock Track","content":"<p>Shares of Personalis (PSNL) surged 5.24% in after-hours trading on Tuesday, following a series of bullish analyst reports and a notable price target increase. The genomic sequencing company's stock received a boost as multiple firms reaffirmed their positive outlook on the company's prospects.</p>\n\n<p>H.C. Wainwright & Co. led the charge by raising its price target on Personalis to $13 from $10, while maintaining a Buy rating. This significant increase in the price target suggests growing confidence in the company's future performance. Additionally, both Guggenheim and BTIG reiterated their Buy ratings on the stock, further solidifying the positive sentiment among analysts.</p>\n\n<p>While Morgan Stanley maintained its Equal-Weight rating on Personalis, the overall bullish stance from other prominent research firms appears to have overshadowed this neutral position. The collective positive analyst sentiment, particularly the raised price target, likely contributed to investors' enthusiasm, driving the stock's after-hours rally.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Personalis Soars 5.24% After-Hours on Bullish Analyst Ratings and Price Target Hike</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Personalis Soars 5.24% After-Hours on Bullish Analyst Ratings and Price Target Hike\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-11-12 05:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Personalis (PSNL) surged 5.24% in after-hours trading on Tuesday, following a series of bullish analyst reports and a notable price target increase. The genomic sequencing company's stock received a boost as multiple firms reaffirmed their positive outlook on the company's prospects.</p>\n\n<p>H.C. Wainwright & Co. led the charge by raising its price target on Personalis to $13 from $10, while maintaining a Buy rating. This significant increase in the price target suggests growing confidence in the company's future performance. Additionally, both Guggenheim and BTIG reiterated their Buy ratings on the stock, further solidifying the positive sentiment among analysts.</p>\n\n<p>While Morgan Stanley maintained its Equal-Weight rating on Personalis, the overall bullish stance from other prominent research firms appears to have overshadowed this neutral position. The collective positive analyst sentiment, particularly the raised price target, likely contributed to investors' enthusiasm, driving the stock's after-hours rally.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PSNL","symbol_name":"Personalis","start_time":0,"source_url":"","article_id":"1146538948","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1146538948","pubTimestamp":1762898305,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Personalis (PSNL) surged 5.24% in after-hours trading on Tuesday, following a series of bullish analyst reports and a notable price target increase. The genomic sequencing company's stock...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PSNL":"Personalis"},"translate_title":"个股追踪|分析师评级看涨和目标价上调Personalis盘后飙升5.24%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PSNL":1},"content_text":"Shares of Personalis (PSNL) surged 5.24% in after-hours trading on Tuesday, following a series of bullish analyst reports and a notable price target increase. The genomic sequencing company's stock received a boost as multiple firms reaffirmed their positive outlook on the company's prospects.\nH.C. Wainwright & Co. led the charge by raising its price target on Personalis to $13 from $10, while maintaining a Buy rating. This significant increase in the price target suggests growing confidence in the company's future performance. Additionally, both Guggenheim and BTIG reiterated their Buy ratings on the stock, further solidifying the positive sentiment among analysts.\nWhile Morgan Stanley maintained its Equal-Weight rating on Personalis, the overall bullish stance from other prominent research firms appears to have overshadowed this neutral position. The collective positive analyst sentiment, particularly the raised price target, likely contributed to investors' enthusiasm, driving the stock's after-hours rally.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1146538948","isCrawlerRequest":true}